Skip to Content

CNN – Health

Booster dose of Pfizer/BioNTech coronavirus vaccine shows 95.6% efficacy in Phase 3 trial, companies say

By Jacqueline Howard, CNN A booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — against Covid-19 in a Phase 3 trial, the companies announced on Thursday. They noted that “efficacy was consistent irrespective of age, sex, race, ethnicity or comorbid conditions.” The trial included more than 10,000

Continue Reading

More people are getting boosters than new Covid-19 vaccinations. And others could soon become eligible for an additional shot

By Madeline Holcombe, CNN The number of people in the US looking to boost their Covid-19 vaccinations has surpassed the tally of those looking to begin them as booster doses from more drug makers may soon be available. There are 1.3 times as many boosters administered each day compared with first shots, data from the

Continue Reading

Pfizer vaccine is 93% effective in preventing Covid-19 hospitalization among adolescents, CDC study finds

By Deidre McPhillips, CNN The Pfizer/BioNTech vaccine is 93% effective in preventing hospitalization due to Covid-19 among children ages 12 to 18, according to a study by the US Centers for Disease Control and Prevention. Vaccine effectiveness differed only slightly within that age group, with 91% effectiveness for children age 12 to 15 and 94%

Continue Reading

More people are getting boosters than new Covid-19 vaccinations. And others could soon become eligible for an additional shot

By Madeline Holcombe, CNN The number of people in the US looking to boost their Covid-19 vaccinations has surpassed the tally of those looking to begin them as booster doses from more drug makers may soon be available. There are 1.3 times as many boosters administered each day compared with first shots, data from the

Continue Reading